A detailed history of Geode Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 36,161,045 shares of ABBV stock, worth $6.35 Billion. This represents 0.59% of its overall portfolio holdings.

Number of Shares
36,161,045
Previous 36,681,750 1.42%
Holding current value
$6.35 Billion
Previous $6.29 Billion 13.5%
% of portfolio
0.59%
Previous 0.56%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $85.3 Million - $104 Million
-520,705 Reduced 1.42%
36,161,045 $7.14 Billion
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $126 Million - $147 Million
-812,903 Reduced 2.17%
36,681,750 $6.29 Billion
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $76.3 Million - $86.9 Million
477,167 Added 1.29%
37,494,653 $6.83 Billion
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $111 Million - $126 Million
810,314 Added 2.24%
37,017,486 $5.74 Billion
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $168 Million - $194 Million
1,254,234 Added 3.59%
36,207,172 $5.4 Billion
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $120 Million - $150 Million
907,917 Added 2.67%
34,952,938 $4.71 Billion
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $42.3 Million - $48.7 Million
292,512 Added 0.87%
34,045,021 $5.43 Billion
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $10.8 Million - $12.9 Million
-77,992 Reduced 0.23%
33,752,509 $5.45 Billion
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $503 Million - $577 Million
3,749,074 Added 12.46%
33,830,501 $4.54 Billion
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $187 Million - $238 Million
1,361,176 Added 4.74%
30,081,427 $4.6 Billion
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $26.6 Million - $33 Million
201,305 Added 0.71%
28,720,251 $4.64 Billion
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $81.5 Million - $103 Million
758,354 Added 2.73%
28,518,946 $3.85 Billion
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $54.9 Million - $62.3 Million
515,643 Added 1.89%
27,760,592 $2.99 Billion
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $1.3 Million - $1.45 Million
12,350 Added 0.05%
27,244,949 $3.06 Billion
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $56.3 Million - $62 Million
550,676 Added 2.06%
27,232,599 $2.94 Billion
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $44 Million - $59.4 Million
546,851 Added 2.09%
26,681,923 $2.85 Billion
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $243 Million - $285 Million
-2,823,520 Reduced 9.75%
26,135,072 $2.28 Billion
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $234 Million - $313 Million
3,185,087 Added 12.36%
28,958,592 $2.84 Billion
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $86.7 Million - $132 Million
1,344,728 Added 5.5%
25,773,505 $1.96 Billion
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $49.2 Million - $61.5 Million
681,783 Added 2.87%
24,428,777 $2.16 Billion
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $96 Million - $115 Million
1,524,799 Added 6.86%
23,746,994 $1.8 Billion
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $53.7 Million - $68.6 Million
817,407 Added 3.82%
22,222,195 $1.61 Billion
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $295 Million - $347 Million
3,822,261 Added 21.74%
21,404,788 $1.72 Billion
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $68.5 Million - $84.5 Million
880,288 Added 5.27%
17,582,527 $1.62 Billion
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $3.26 Million - $3.62 Million
36,620 Added 0.22%
16,702,239 $1.58 Billion
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $44.4 Million - $52.6 Million
-494,832 Reduced 2.88%
16,665,619 $1.54 Billion
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $103 Million - $138 Million
1,117,600 Added 6.97%
17,160,451 $1.62 Billion
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $62.4 Million - $68.5 Million
697,191 Added 4.54%
16,042,851 $1.55 Billion
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $22.4 Million - $28.7 Million
321,142 Added 2.14%
15,345,660 $1.36 Billion
Q2 2017

Aug 14, 2017

BUY
N/A
15,024,518
15,024,518 $1.09 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.